Vectivbio
VectivBio is a clinical-stage biotechnology company.
Total raised
€306M
€305,509,070
Funding rounds
4
Investors
13
distinct backers
Active since
2020-08
latest 2022-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood28
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €100M+ raised
- ▲ 7y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-20 | Other | €128M | Cowen Healthcare Investments,Driehaus Capital Management,Eventide Asset Management,Forbion's Growth Opportunities Fund,Frazier Life Sciences,Marshall Wace+5 more | View deal → |
| 2022-07-05 | Other | €53M | Forbion Capital Partners,Private investor | View deal → |
| 2020-10-19 | Other | €93M | — | View deal → |
| 2020-09-01 | Series A | €32M | — | View deal → |
Investors
13Related news
- VectivBio raises $125 millionstartupticker.ch · 2022-10
- VectivBio Announces Closing of $54 Million Aggregate Financingstartupticker.ch · 2022-07
- finsmes.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy